STOCK TITAN
  1. Home
  2. Sec-filings
  3. TWST
  4. [144] Twist Bioscience Corp SEC Filing

Twist Bioscience officer plans sale of 4,046 shares

Twist Bioscience Corp (symbol TWST) received a notice that officer Patrick Finn plans to sell 4,046 shares of its common stock.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Twist Bioscience Corp (symbol TWST) received a notice that officer Patrick Finn plans to sell 4,046 shares of its common stock. The shares are tied to restricted stock vesting dated August 20, 2026, with the transaction described as compensation-related and executed through Fidelity Brokerage Services LLC on NASDAQ.

Over the prior three months, Patrick Finn reported sales of Twist Bioscience common stock on May 21, 2026 (4,160 shares), July 23, 2026 (2,238 shares), August 3, 2026 (2,888 shares), and August 18, 2026 (78,355 shares). The filing notes that the sale includes an amount needed to cover a tax obligation from the settlement of a vested equity award.

Positive

  • None.

Negative

  • None.
Planned sale shares 4,046 shares Common stock to be sold related to restricted stock vesting dated August 20, 2026
Shares sold May 21, 2026 4,160 shares Common stock sold by Patrick Finn during the past 3 months
Proceeds May 21, 2026 $221,547.45 Dollar amount reported for the May 21, 2026 common stock sale
Shares sold July 23, 2026 2,238 shares Common stock sold by Patrick Finn during the past 3 months
Proceeds July 23, 2026 $210,132.53 Dollar amount reported for the July 23, 2026 common stock sale
Shares sold August 3, 2026 2,888 shares Common stock sold by Patrick Finn during the past 3 months
Shares sold August 18, 2026 78,355 shares Largest single common stock sale reported in the past 3 months
Proceeds August 18, 2026 $9,217,606.64 Dollar amount reported for the August 18, 2026 common stock sale
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Common | 08/20/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Patrick Finn"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
equity award distribution financial
"resulting from the settlement of a vested equity award distribution."

FAQ

What does the Form 144 filing disclose for Twist Bioscience Corp (TWST)?
It discloses that officer Patrick Finn has filed a notice of intent to sell 4,046 shares of Twist Bioscience common stock, related to restricted stock vesting dated August 20, 2026, with sales to be handled through Fidelity Brokerage Services LLC.

How many TWST shares is Patrick Finn planning to sell under this Form 144?
Patrick Finn plans to sell 4,046 shares of Twist Bioscience common stock. The shares are associated with a restricted stock vesting event dated August 20, 2026 and are reported as compensation-related securities to be sold.

What TWST share sales has Patrick Finn reported in the past three months?
He reported Twist Bioscience common stock sales of 4,160 shares on May 21, 2026, 2,238 shares on July 23, 2026, 2,888 shares on August 3, 2026, and 78,355 shares on August 18, 2026, each with corresponding dollar amounts disclosed.

What total dollar amounts were reported for Patrick Finn’s recent TWST sales?
Reported sale proceeds were $221,547.45 on May 21, 2026, $210,132.53 on July 23, 2026, $246,407.63 on August 3, 2026, and $9,217,606.64 on August 18, 2026, all for Twist Bioscience common stock.

Why does the Form 144 say some TWST shares are being sold by Patrick Finn?
The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating part of the transaction is for tax-related purposes tied to equity compensation.

Who is executing the planned TWST share sale for Patrick Finn?
The planned sale of 4,046 shares of Twist Bioscience common stock is listed through Fidelity Brokerage Services LLC, with the Form 144 signed by Daniel Tucci as a duly authorized representative and attorney-in-fact for Patrick Finn.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR